EMEA (Europe, Middle East and Africa) Pertussis Vaccine Market Report 2017

October 2017 | 109 pages | ID: EB3F4C3485BWEN
QYResearch

Abstracts

In this report, the EMEA Pertussis Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (10 K Doses), revenue (Million USD), market share and growth rate of Pertussis Vaccine for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pertussis Vaccine market competition by top manufacturers/players, with Pertussis Vaccine sales volume (10 K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi Pasteur
• GSK
• Mitsubishi Tanabe Pharma Corporation
• Astellas Pharma
• Minhai Biotechnology
• Wuhan Institute of Biological Products
• Changchun Changsheng Life Sciences
• Beijing Tiantan Biological Products
• Chengdu Institute of Biological Products

On the basis of product, this report displays the sales volume (10 K Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into

• Whole-cell Vaccines
• Acellular Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (10 K Doses), market share and growth rate of Pertussis Vaccine for each application, including

• Children Application
• Adults Application

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Pertussis Vaccine Market Report 2017

1 PERTUSSIS VACCINE OVERVIEW

1.1 Product Overview and Scope of Pertussis Vaccine
1.2 Classification of Pertussis Vaccine
  1.2.1 EMEA Pertussis Vaccine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Pertussis Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Whole-cell Vaccines
  1.2.4 Acellular Vaccines
1.3 EMEA Pertussis Vaccine Market by Application/End Users
  1.3.1 EMEA Pertussis Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Children Application
  1.3.3 Adults Application
1.4 EMEA Pertussis Vaccine Market by Region
  1.4.1 EMEA Pertussis Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Pertussis Vaccine (2012-2022)
  1.5.1 EMEA Pertussis Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Pertussis Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA PERTUSSIS VACCINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Pertussis Vaccine Market Competition by Players/Manufacturers
  2.1.1 EMEA Pertussis Vaccine Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Pertussis Vaccine Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Pertussis Vaccine Sale Price by Players (2012-2017)
2.2 EMEA Pertussis Vaccine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Pertussis Vaccine Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Pertussis Vaccine Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Pertussis Vaccine Sale Price by Type (2012-2017)
2.3 EMEA Pertussis Vaccine (Volume) by Application
2.4 EMEA Pertussis Vaccine (Volume and Value) by Region
  2.4.1 EMEA Pertussis Vaccine Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Pertussis Vaccine Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Pertussis Vaccine Sales Price by Region (2012-2017)

3 EUROPE PERTUSSIS VACCINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Pertussis Vaccine Sales and Value (2012-2017)
  3.1.1 Europe Pertussis Vaccine Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Pertussis Vaccine Revenue and Growth Rate (2012-2017)
3.2 Europe Pertussis Vaccine Sales and Market Share by Type
3.3 Europe Pertussis Vaccine Sales and Market Share by Application
3.4 Europe Pertussis Vaccine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Pertussis Vaccine Sales Volume by Countries (2012-2017)
  3.4.2 Europe Pertussis Vaccine Revenue by Countries (2012-2017)
  3.4.3 Germany Pertussis Vaccine Sales and Growth Rate (2012-2017)
  3.4.4 France Pertussis Vaccine Sales and Growth Rate (2012-2017)
  3.4.5 UK Pertussis Vaccine Sales and Growth Rate (2012-2017)
  3.4.6 Russia Pertussis Vaccine Sales and Growth Rate (2012-2017)
  3.4.7 Italy Pertussis Vaccine Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Pertussis Vaccine Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PERTUSSIS VACCINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Pertussis Vaccine Sales and Value (2012-2017)
  4.1.1 Middle East Pertussis Vaccine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Pertussis Vaccine Revenue and Growth Rate (2012-2017)
4.2 Middle East Pertussis Vaccine Sales and Market Share by Type
4.3 Middle East Pertussis Vaccine Sales and Market Share by Application
4.4 Middle East Pertussis Vaccine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Pertussis Vaccine Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Pertussis Vaccine Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Pertussis Vaccine Sales and Growth Rate (2012-2017)
  4.4.4 Israel Pertussis Vaccine Sales and Growth Rate (2012-2017)
  4.4.5 UAE Pertussis Vaccine Sales and Growth Rate (2012-2017)
  4.4.6 Iran Pertussis Vaccine Sales and Growth Rate (2012-2017)

5 AFRICA PERTUSSIS VACCINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Pertussis Vaccine Sales and Value (2012-2017)
  5.1.1 Africa Pertussis Vaccine Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Pertussis Vaccine Revenue and Growth Rate (2012-2017)
5.2 Africa Pertussis Vaccine Sales and Market Share by Type
5.3 Africa Pertussis Vaccine Sales and Market Share by Application
5.4 Africa Pertussis Vaccine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Pertussis Vaccine Sales Volume by Countries (2012-2017)
  5.4.2 Africa Pertussis Vaccine Revenue by Countries (2012-2017)
  5.4.3 South Africa Pertussis Vaccine Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Pertussis Vaccine Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Pertussis Vaccine Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Pertussis Vaccine Sales and Growth Rate (2012-2017)

6 EMEA PERTUSSIS VACCINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Sanofi Pasteur
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pertussis Vaccine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GSK
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Pertussis Vaccine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Mitsubishi Tanabe Pharma Corporation
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Pertussis Vaccine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Astellas Pharma
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Pertussis Vaccine Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Astellas Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Minhai Biotechnology
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Pertussis Vaccine Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Wuhan Institute of Biological Products
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Pertussis Vaccine Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Changchun Changsheng Life Sciences
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Pertussis Vaccine Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Changchun Changsheng Life Sciences Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Beijing Tiantan Biological Products
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Pertussis Vaccine Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Beijing Tiantan Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Chengdu Institute of Biological Products
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Pertussis Vaccine Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Chengdu Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 PERTUSSIS VACCINE MANUFACTURING COST ANALYSIS

7.1 Pertussis Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pertussis Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pertussis Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pertussis Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PERTUSSIS VACCINE MARKET FORECAST (2017-2022)

11.1 EMEA Pertussis Vaccine Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Pertussis Vaccine Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Pertussis Vaccine Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Pertussis Vaccine Price and Trend Forecast (2017-2022)
11.2 EMEA Pertussis Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Pertussis Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Pertussis Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Pertussis Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Pertussis Vaccine Sales Forecast by Type (2017-2022)
11.7 EMEA Pertussis Vaccine Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pertussis Vaccine
Figure EMEA Pertussis Vaccine Sales Volume (10 K Doses) by Type (2012-2022)
Figure EMEA Pertussis Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Whole-cell Vaccines Product Picture
Figure Acellular Vaccines Product Picture
Figure EMEA Pertussis Vaccine Sales Volume (10 K Doses) by Application (2012-2022)
Figure EMEA Sales Market Share of Pertussis Vaccine by Application in 2016
Figure Children Application Examples
Table Key Downstream Customer in Children Application
Figure Adults Application Examples
Table Key Downstream Customer in Adults Application
Figure EMEA Pertussis Vaccine Market Size (Million USD) by Region (2012-2022)
Figure Europe Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Pertussis Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Pertussis Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Pertussis Vaccine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Pertussis Vaccine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Pertussis Vaccine Market Major Players Product Sales Volume (10 K Doses) (2012-2017)
Table EMEA Pertussis Vaccine Sales Volume (10 K Doses) of Major Players (2012-2017)
Table EMEA Pertussis Vaccine Sales Share by Players (2012-2017)
Figure 2016 Pertussis Vaccine Sales Share by Players
Figure 2017 Pertussis Vaccine Sales Share by Players
Figure EMEA Pertussis Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Pertussis Vaccine Revenue (Million USD) by Players (2012-2017)
Table EMEA Pertussis Vaccine Revenue Share by Players (2012-2017)
Table 2016 EMEA Pertussis Vaccine Revenue Share by Players
Table 2017 EMEA Pertussis Vaccine Revenue Share by Players
Table EMEA Pertussis Vaccine Sale Price (USD/Dose) by Players (2012-2017)
Table EMEA Pertussis Vaccine Sales (10 K Doses) and Market Share by Type (2012-2017)
Table EMEA Pertussis Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Pertussis Vaccine by Type (2012-2017)
Figure EMEA Pertussis Vaccine Sales Market Share by Type (2012-2017)
Table EMEA Pertussis Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Pertussis Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pertussis Vaccine by Type in 2016
Table EMEA Pertussis Vaccine Sale Price (USD/Dose) by Type (2012-2017)
Table EMEA Pertussis Vaccine Sales (10 K Doses) and Market Share by Application (2012-2017)
Table EMEA Pertussis Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Pertussis Vaccine by Application (2012-2017)
Figure EMEA Pertussis Vaccine Sales Market Share by Application in 2016
Table EMEA Pertussis Vaccine Sales (10 K Doses) and Market Share by Region (2012-2017)
Table EMEA Pertussis Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Pertussis Vaccine by Region (2012-2017)
Figure EMEA Pertussis Vaccine Sales Market Share in 2016
Table EMEA Pertussis Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Pertussis Vaccine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Pertussis Vaccine by Region (2012-2017)
Figure EMEA Pertussis Vaccine Revenue Market Share Regions in 2016
Table EMEA Pertussis Vaccine Sales Price (USD/Dose) by Region (2012-2017)
Figure Europe Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Europe Pertussis Vaccine Revenue and Growth Rate (2012-2017)
Table Europe Pertussis Vaccine Sales (10 K Doses) by Type (2012-2017)
Table Europe Pertussis Vaccine Market Share by Type (2012-2017)
Figure Europe Pertussis Vaccine Market Share by Type in 2016
Table Europe Pertussis Vaccine Sales (10 K Doses) by Application (2012-2017)
Table Europe Pertussis Vaccine Market Share by Application (2012-2017)
Figure Europe Pertussis Vaccine Market Share by Application in 2016
Table Europe Pertussis Vaccine Sales (10 K Doses) by Countries (2012-2017)
Table Europe Pertussis Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Pertussis Vaccine Sales Market Share by Countries (2012-2017)
Figure Europe Pertussis Vaccine Sales Market Share by Countries in 2016
Table Europe Pertussis Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Europe Pertussis Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Pertussis Vaccine Revenue Market Share by Countries (2012-2017)
Figure Europe Pertussis Vaccine Revenue Market Share by Countries in 2016
Figure Germany Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure France Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure UK Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Russia Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Italy Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Benelux Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Middle East Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Middle East Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Pertussis Vaccine Sales (10 K Doses) by Type (2012-2017)
Table Middle East Pertussis Vaccine Market Share by Type (2012-2017)
Figure Middle East Pertussis Vaccine Market Share by Type (2012-2017)
Table Middle East Pertussis Vaccine Sales (10 K Doses) by Applications (2012-2017)
Table Middle East Pertussis Vaccine Market Share by Applications (2012-2017)
Figure Middle East Pertussis Vaccine Sales Market Share by Application in 2016
Table Middle East Pertussis Vaccine Sales Volume (10 K Doses) by Countries (2012-2017)
Table Middle East Pertussis Vaccine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Pertussis Vaccine Sales Volume Market Share by Countries in 2016
Table Middle East Pertussis Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Pertussis Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Pertussis Vaccine Revenue Market Share by Countries (2012-2017)
Figure Middle East Pertussis Vaccine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Israel Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure UAE Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Iran Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Africa Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Africa Pertussis Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Pertussis Vaccine Sales (10 K Doses) by Type (2012-2017)
Table Africa Pertussis Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Pertussis Vaccine Sales Market Share by Type (2012-2017)
Figure Africa Pertussis Vaccine Sales Market Share by Type in 2016
Table Africa Pertussis Vaccine Sales (10 K Doses) by Application (2012-2017)
Table Africa Pertussis Vaccine Sales Market Share by Application (2012-2017)
Figure Africa Pertussis Vaccine Sales Market Share by Application (2012-2017)
Table Africa Pertussis Vaccine Sales Volume (10 K Doses) by Countries (2012-2017)
Table Africa Pertussis Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Pertussis Vaccine Sales Market Share by Countries (2012-2017)
Figure Africa Pertussis Vaccine Sales Market Share by Countries in 2016
Table Africa Pertussis Vaccine Revenue (Million USD) by Countries (2012-2017)
Table Africa Pertussis Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Pertussis Vaccine Revenue Market Share by Countries (2012-2017)
Figure Africa Pertussis Vaccine Revenue Market Share by Countries in 2016
Figure South Africa Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Nigeria Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Egypt Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Algeria Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Table Sanofi Pasteur Pertussis Vaccine Basic Information List
Table Sanofi Pasteur Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Sanofi Pasteur Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Sanofi Pasteur Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Sanofi Pasteur Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table GSK Pertussis Vaccine Basic Information List
Table GSK Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure GSK Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure GSK Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure GSK Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Basic Information List
Table Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Mitsubishi Tanabe Pharma Corporation Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Astellas Pharma Pertussis Vaccine Basic Information List
Table Astellas Pharma Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Astellas Pharma Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Astellas Pharma Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Astellas Pharma Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Minhai Biotechnology Pertussis Vaccine Basic Information List
Table Minhai Biotechnology Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Minhai Biotechnology Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Minhai Biotechnology Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Minhai Biotechnology Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Wuhan Institute of Biological Products Pertussis Vaccine Basic Information List
Table Wuhan Institute of Biological Products Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Wuhan Institute of Biological Products Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Wuhan Institute of Biological Products Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Wuhan Institute of Biological Products Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Changchun Changsheng Life Sciences Pertussis Vaccine Basic Information List
Table Changchun Changsheng Life Sciences Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Changchun Changsheng Life Sciences Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Changchun Changsheng Life Sciences Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Changchun Changsheng Life Sciences Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Beijing Tiantan Biological Products Pertussis Vaccine Basic Information List
Table Beijing Tiantan Biological Products Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Beijing Tiantan Biological Products Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Beijing Tiantan Biological Products Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Beijing Tiantan Biological Products Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Chengdu Institute of Biological Products Pertussis Vaccine Basic Information List
Table Chengdu Institute of Biological Products Pertussis Vaccine Sales (10 K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Chengdu Institute of Biological Products Pertussis Vaccine Sales (10 K Doses) and Growth Rate (2012-2017)
Figure Chengdu Institute of Biological Products Pertussis Vaccine Sales Market Share in EMEA (2012-2017)
Figure Chengdu Institute of Biological Products Pertussis Vaccine Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pertussis Vaccine
Figure Manufacturing Process Analysis of Pertussis Vaccine
Figure Pertussis Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Pertussis Vaccine Major Manufacturers in 2016
Table Major Buyers of Pertussis Vaccine
Table Distributors/Traders List
Figure EMEA Pertussis Vaccine Sales (10 K Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Pertussis Vaccine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Pertussis Vaccine Price (USD/Dose) and Trend Forecast (2017-2022)
Table EMEA Pertussis Vaccine Sales (10 K Doses) Forecast by Region (2017-2022)
Figure EMEA Pertussis Vaccine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Pertussis Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Pertussis Vaccine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Pertussis Vaccine Sales (10 K Doses) Forecast by Countries (2017-2022)
Figure Europe Pertussis Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Pertussis Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Pertussis Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Pertussis Vaccine Sales (10 K Doses) Forecast by Countries (2017-2022)
Figure Middle East Pertussis Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Pertussis Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Pertussis Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Pertussis Vaccine Sales (10 K Doses) Forecast by Countries (2017-2022)
Figure Africa Pertussis Vaccine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Pertussis Vaccine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Pertussis Vaccine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Pertussis Vaccine Sales (10 K Doses) Forecast by Type (2017-2022)
Figure EMEA Pertussis Vaccine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Pertussis Vaccine Sales (10 K Doses) Forecast by Application (2017-2022)
Figure EMEA Pertussis Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources